Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5443)
All Articles published online
|
Dec 14, 2006 (publication date) through Nov 15, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Savidou I, Deutsch M, Soultati AS, Koudouras D, Kafiri G, Dourakis SP. Hepatotoxicity induced by cyproterone acetate: A report of three cases. World J Gastroenterol 2006; 12(46): 7551-7555 [PMID: 17167851 DOI: 10.3748/wjg.v12.i46.7551] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i46/7551.htm |
| Number | Citing Articles |
| 1 |
Husein Husein-ElAhmed, Rosa Ortega-Del Olmo. Tratamiento hormonal del acné. Piel 2013; 28(5): 309 doi: 10.1016/j.piel.2012.11.013
|
| 2 |
Jonette Keri, Diane S. Berson, Diane M. Thiboutot. Acne Vulgaris. 2011; : 146 doi: 10.3109/9781616310097.006.1
|
| 3 |
V. Thanaraj, A. Woywodt. Rhabdomyolysis and elevated liver function tests--what's the underlying cause?. Clinical Kidney Journal 2011; 4(6): 447 doi: 10.1093/ndtplus/sfr154
|
| 4 |
Jennifer J. Liang, Divya Jolly, Kelly J. Chan, Joshua D. Safer. Testosterone Levels Achieved by Medically Treated Transgender Women in a United States Endocrinology Clinic Cohort. Endocrine Practice 2018; 24(2): 135 doi: 10.4158/EP-2017-0116
|
| 5 |
Michael Gold. Clascoterone cream (1%) topical androgen receptor inhibitor for the treatment of acne in patients 12 years and older. Expert Review of Clinical Immunology 2021; 17(4): 301 doi: 10.1080/1744666X.2021.1894131
|
| 6 |
V. Bettoli, S. Zauli, A. Virgili. Is hormonal treatment still an option in acne today?. British Journal of Dermatology 2015; 172: 37 doi: 10.1111/bjd.13681
|
| 7 |
Y. N. Ostapenko, K. M. Brusin, Y. V. Zobnin, A. Y. Shchupak, M. K. Vishnevetskiy, V. G. Sentsov, O. V. Novikova, S. A. Alekseenko, O. A. Lebed'Ko, Y. B. Puchkov. Acute cholestatic liver injury caused by polyhexamethyleneguanidine hydrochloride admixed to ethyl alcohol. Clinical Toxicology 2011; 49(6): 471 doi: 10.3109/15563650.2011.592837
|
| 8 |
A. P. Hall, C. R. Elcombe, J. R. Foster, T. Harada, W. Kaufmann, A. Knippel, K. Küttler, D. E. Malarkey, R. R. Maronpot, A. Nishikawa, T. Nolte, A. Schulte, V. Strauss, M. J. York. Liver Hypertrophy. Toxicologic Pathology 2012; 40(7): 971 doi: 10.1177/0192623312448935
|
| 9 |
Raymond Fung, Miriam Hellstern-Layefsky, Iliana Lega. Is a lower dose of cyproterone acetate as effective at testosterone suppression in transgender women as higher doses?. International Journal of Transgenderism 2017; 18(2): 123 doi: 10.1080/15532739.2017.1290566
|
| 10 |
Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 2007; 16(7) doi: 10.1002/pds.1378
|
| 11 |
Maria Cristina Meriggiola, Giulia Gava. Endocrine care of transpeople part II. A review of cross‐sex hormonal treatments, outcomes and adverse effects in transwomen. Clinical Endocrinology 2015; 83(5): 607 doi: 10.1111/cen.12754
|
| 12 |
Husein Husein-ElAhmed. Management of acne vulgaris with hormonal therapies in adult female patients. Dermatologic Therapy 2015; 28(3): 166 doi: 10.1111/dth.12231
|
| 13 |
Cherinne Arundel, James H Lewis. Drug-induced liver disease in 2006. Current Opinion in Gastroenterology 2007; 23(3): 244 doi: 10.1097/MOG.0b013e3280b17dfb
|
| 14 |
Alessandra D. Fisher, Louis Gooren. Encyclopedia of Endocrine Diseases. 2019; : 656 doi: 10.1016/B978-0-12-801238-3.66087-7
|
| 15 |
Ludovico Abenavoli, Natasa Milic, Michel Beaugrand. Severe hepatitis induced by cyproterone acetate: role of corticosteroids. A case report. Annals of Hepatology 2013; 12(1): 152 doi: 10.1016/S1665-2681(19)31399-7
|
| 16 |
Jonette Keri, Diane Berson, Diane Thiboutot. Acne Vulgaris. 2011; : 146 doi: 10.3109/9781616310097-16
|
| 17 |
Yutong Yuan, Jingxuan Zhou, Nanhai Zhang, Xin Xing, Liang Zhao, Feng Zhou. In vivo study of orange peel fermentation and improvement of androgen overproduction causing acne. Food Bioscience 2023; 56: 103124 doi: 10.1016/j.fbio.2023.103124
|
| 18 |
Giulia Gava, Silvia Cerpolini, Valentina Martelli, Giuseppe Battista, Renato Seracchioli, Maria Cristina Meriggiola. Cyproterone acetate vs leuprolide acetate in combination with transdermal oestradiol in transwomen: a comparison of safety and effectiveness. Clinical Endocrinology 2016; 85(2): 239 doi: 10.1111/cen.13050
|
| 19 |
Giulia Gava, Renato Seracchioli, Maria Cristina Meriggiola. Endocrinology of the Testis and Male Reproduction. Endocrinology 2017; : 1199 doi: 10.1007/978-3-319-44441-3_42
|
| 20 |
Giulia Gava, Renato Seracchioli, Maria Cristina Meriggiola. Thyroid Diseases. Endocrinology 2017; : 1 doi: 10.1007/978-3-319-29456-8_42-1
|
| 21 |
E.H.A. Ali. Protective Effects of Echinacea on Cyproterone Acetate Induced Liver Damage in Male Rats. Pakistan Journal of Biological Sciences 2008; 11(21): 2464 doi: 10.3923/pjbs.2008.2464.2471
|
| 22 |
Shivani V Tripathi, Cheryl J Gustafson, Karen E Huang, Steven R Feldman. Side effects of common acne treatments. Expert Opinion on Drug Safety 2013; 12(1): 39 doi: 10.1517/14740338.2013.740456
|
| 23 |
Pramod Kumar, Sujith Reddy, Anand Kulkarni, Mithun Sharma, Padaki N. Rao. Cyproterone Acetate–Induced Acute Liver Failure: A Case Report and Review of the Literature. Journal of Clinical and Experimental Hepatology 2021; 11(6): 739 doi: 10.1016/j.jceh.2021.01.003
|
| 24 |
Pallav Sengupta, Sulagna Dutta. Chemosterilization in Male: ‘Past And Present’ in Reproductive Biology. Biomedical and Pharmacology Journal 2022; 15(1): 1 doi: 10.13005/bpj/2336
|
| 25 |
Henry L. Nguyen, Megha M. Tollefson. Endocrine disorders and hormonal therapy for adolescent acne. Current Opinion in Pediatrics 2017; 29(4): 455 doi: 10.1097/MOP.0000000000000515
|
| 26 |
Wei Ding, Michelle E. Bishop, Mason G. Pearce, Kelly J. Davis, Gene A. White, Lascelles E. Lyn-Cook, Mugimane G. Manjanatha. Sex-specific dose-response analysis of genotoxicity in cyproterone acetate-treated F344 rats. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2014; 774: 1 doi: 10.1016/j.mrgentox.2014.08.005
|
| 27 |
Edmundo A. Rodriguez-Frias, William M. Lee. Cancer Chemotherapy II: Atypical Hepatic Injuries. Clinics in Liver Disease 2007; 11(3): 663 doi: 10.1016/j.cld.2007.06.012
|
| 28 |
Fernando Bessone, MI Lucena, Marcelo G. Roma, Camilla Stephens, Inmaculada Medina‐Cáliz, Bernardo Frider, Guillermo Tsariktsian, Nelia Hernández, Miquel Bruguera, Gisela Gualano, Eduardo Fassio, Joaquín Montero, María V Reggiardo, Sebastián Ferretti, Luis Colombato, Federico Tanno, Jaime Ferrer, Lelio Zeno, Hugo Tanno, Raúl J. Andrade. Cyproterone acetate induces a wide spectrum of acute liver damage including corticosteroid‐responsive hepatitis: report of 22 cases. Liver International 2016; 36(2): 302 doi: 10.1111/liv.12899
|
| 29 |
Elleuch Nour, Ksiaa Mehdi, Jaziri Hanene, Aya Hammami, Aida Ben Slama, Jmaa Ali. Fatal acute liver failure induced by cyproterone acetate: A new case. La Presse Médicale 2017; 46(12): 1231 doi: 10.1016/j.lpm.2017.09.003
|
| 30 |
Wendi D. Roe, Katja Geschke, Chris Pease. Fatal Fulminant Hepatitis in a Chimpanzee (Pan troglodytes) Receiving Cyproterone Acetate. Journal of Zoo and Wildlife Medicine 2009; 40(4): 799 doi: 10.1638/2009-0031.1
|